Clinical Trial Update: A Study of ASP546C in Adults With Gastroesophageal Cancer, Pancreatic Cancer or Other Solid Tumors [Phase 1, Phase 2]

View source ↗

Summary

A Phase 1/2 clinical trial evaluating ASP546C in adults with gastric/GEJ adenocarcinoma, pancreatic adenocarcinoma, or other solid tumors is currently recruitin…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Gastric Adenocarcinoma
• Gastroesophageal Junction Adenocarcinoma
• Pancreatic Adenocarcinoma

Drugs mentioned

• ASP546C (ASP546C)

Snippet

Sponsor: Astellas Pharma Global Development, Inc. | Conditions: Gastric or Gastro-esophageal Junction (GEJ) Adenocarcinoma, Pancreatic Adenocarcinoma | Phase 1, Phase 2 | Status: RECRUITING